The Journal of Immunology, Vol 136, Issue 5 1648-1653, Copyright © 1986 by American Association of Immunologists

ARTICLES

Identification of Ki (Ku, p70/p80) autoantigens and analysis of anti-Ki autoantibody reactivity

AM Francoeur, CL Peebles, PT Gompper and EM Tan

Anti-Ki (Ku, p70/p80) autoantibodies, named after the prototype patient Kikuta by Tojo et al., occur in approximately 10% of patients with SLE, often in association with anti-Sm autoantibodies. The immunofluorescent staining pattern characteristic of anti-Ki antibodies is diffuse speckled nuclear, although some substrates show nucleolar staining as well. Anti-Ki sera specifically immunoprecipitated two protein antigens, Ki86 (Mr 86,000) and Ki66 (Mr 66,000), from radiolabeled cell extracts. The Ki system was found to be immunologically identical to the Ku system described by Mimori et al. and the p70/p80 system described by Reeves. The Ki primary in vitro translation products were identified and proved similar in size to the cellular antigens. The Ki antigens were purified from human spleen by immunoaffinity chromatography followed by SDS-PAGE. The purified Ki antigens proved to be closely related by amino acid composition, and did not appear to be phosphorylated, glycosylated, or associated with RNA. The Ki antigens were found to bind to DNA, in agreement with the observations on the Ku and p70/p80 antigens. They were found to be widely conserved in mammals and were coordinately expressed in all tissues tested. Anti-Ki autoantibodies were purified by antigen-affinity chromatography and were tested by immunoblotting. The antibodies were classified as class I, II, or III, depending on their reactivity with the Ki antigens in immunoblots. Class I antibodies cross-reacted with both Ki antigens, class II antibodies reacted solely with Ki66, and class III antibodies reacted solely with Ki86. These results suggest that at least three different epitopes are present on the Ki autoantigens and that patients differ in their autoantibody response to each epitope.

This article has been cited by other articles:

				B Rozman, S Cucnik, S Sodin-Semrl, L Czirjak, C Varju, O Distler, D Huscher, M Aringer, G Steiner, M Matucci-Cerinic, et al. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study Ann Rheum Dis, September 1, 2008; 67(9): 1282 - 1286. [Abstract] [Full Text] [PDF]

				I Cavazzana, F Franceschini, C Vassalini, E Danieli, M Quinzanini, P Airo, and R Cattaneo Clinical and serological features of 35 patients with anti-Ki autoantibodies Lupus, October 1, 2005; 14(10): 837 - 841. [Abstract] [PDF]

				P. Frit, Y. Canitrot, C. Muller, N. Foray, P. Calsou, E. Marangoni, J. Bourhis, and B. Salles Cross-Resistance to Ionizing Radiation in a Murine Leukemic Cell Line Resistant to cis-Dichlorodiammineplatinum(II): Role of Ku Autoantigen Mol. Pharmacol., July 1, 1999; 56(1): 141 - 146. [Abstract] [Full Text]

				T. M. Bliss and D. P. Lane Ku Selectively Transfers between DNA Molecules with Homologous Ends J. Biol. Chem., February 28, 1997; 272(9): 5765 - 5773. [Abstract] [Full Text] [PDF]

				N. Warriar, N. Page, and M. V. Govindan Expression of Human Glucocorticoid Receptor Gene and Interaction of Nuclear Proteins with the Transcriptional Control Element J. Biol. Chem., August 2, 1996; 271(31): 18662 - 18671. [Abstract] [Full Text] [PDF]

				D. B. Jacoby and P. C. Wensink DNA Binding Specificities of YPF1, a Drosophila Homolog to the DNA Binding Subunit of Human DNA-dependent Protein Kinase, Ku J. Biol. Chem., July 12, 1996; 271(28): 16827 - 16832. [Abstract] [Full Text] [PDF]

				J. Fewell and E. Kuff Intracellular redistribution of Ku immunoreactivity in response to cell-cell contact and growth modulating components in the medium J. Cell Sci., January 7, 1996; 109(7): 1937 - 1946. [Abstract] [PDF]

				A Kuhn, T M Gottlieb, S P Jackson, and I Grummt DNA-dependent protein kinase: a potent inhibitor of transcription by RNA polymerase I. Genes & Dev., January 15, 1995; 9(2): 193 - 203. [Abstract] [PDF]